February 11th, the daily limit is known early: Seven major benefits are expected to ferment

February 11th, the daily limit is known early: Seven major benefits are expected to ferment

CPI exceeds 西安耍耍网 expectations, which industries can invest?

Investing without looking at policies is like blindfolding. Come to Sina Finance University, listen to Miss Dong read the news, and understand the market.

  Sina Finance News on February 10 news, there are seven major benefits that may affect the stock market tomorrow, specifically: First Travel Hotel: The controlling shareholder intends to increase its holdings to zero.

5% -2% shares of BTG Hotels (600258) announced on the evening of February 10 that the company’s controlling shareholder, BTG Group, intends to increase its holdings in the next 6 months by no less than 0 of the company’s issued shares.

5%, not more than 2% of the company’s issued shares.

  Zhenhai shares: The actual controller of the company will be changed to Yuyao State-owned Assets Management Office Zhenhai shares (603637) In the evening of February 苏州桑拿网 10, shareholders signed a share transfer agreement. Zhao Liwei, Fan Qihai, Fan Xiaomei, Weng Wei and other 97 natural persons held it.1999.

320,000 shares of the company (11% of the company’s share capital).

48%) The agreement was transferred to Shuntong Group.

At the same time, Shuntong Group, Shunjian Group, Zhao Liwei, Fan Qihai, Fan Xiaomei, and Weng Wei signed the Agreement for Concerted Action.

The controlling shareholder of the company will be changed to Shuntong Group and its concerted parties, and the actual controller will be changed to Yuyao State-owned Assets Management Office.

  Health Yuan: To be 1.

5ppm-300 million repurchase of shares Health Yuan (600380) announced on the evening of February 10 that the company plans to repurchase the company’s shares in a centralized bidding transaction with a repurchase fund size of not less than 1.

5 trillion and not more than 3 trillion, the repurchase price does not exceed 15 yuan / share.

  Shellett: There are too many orders for ultraviolet germicidal lamps Shellett (002076) announced on the evening of the 10th that there are too many orders for ultraviolet germicidal lamps. The company has resumed work in advance. Due to the pneumonia epidemic of new coronavirus infection, the company’s number of workers and supply chain have been affectedTo some extent, production capacity is gradually recovering.

The company has gathered all its power to speed up production and quickly restore production capacity. It is expected that after the upstream suppliers gradually resume orderly work, the company’s supply chain will be more assured and output will be greatly increased.

According to the company’s “Semi-annual Report 2019”, the sales revenue of the company’s ultraviolet germicidal lamps (environmental purification series) related products accounted for 20% of the company’s overall revenue.

  Jinan Guoji (002636) announced on the evening of February 10th. On February 5th, the National Health Committee and the State Administration of Traditional Chinese Medicine jointly released Jinan Guoji: Fangfeng Tongsheng Pill products included in the “Pneumonitis Diagnosis and Treatment Program for New Coronavirus”.Diagnosis and treatment of pneumonitis caused by a new coronavirus (trial version 5).

The company’s subsidiary, Chengde Tianyuan Pharmaceutical Co., Ltd., produced Fengfang Tongsheng Pills (granules) as the recommended drug for the observation period of the Chinese medicine treatment hospital under this plan.

  Guangshengtang: launching anti-2019-nCoV drug developmentG3, a complete set of clinical approval data for two generic drugs used in the clinical research of new coronavirus pneumonia.

On February 7th, the clinical “Small sample pre-experimental study of pneumonitis with mild or moderate new coronavirus infection by G2 or G3 alternative pharmaceuticals for clinical use” received clinical approval, and it is now proceeding in an orderly manner.

  Proton Technology: Proposed to cooperate with Haseeki in the field of VR / AR content and technology. Baotong Technology (300031) announced on the evening of February 10 that the company and Haseeki signed a business cooperation agreement to enhance virtual reality (VR)Real-world (AR) content engages in in-depth business cooperation with technology.

Hashiqi is a top domestic VR / AR content and solution provider, with more than 10 outstanding VR / AR game products.